Eun Joo Yang1, Sung-Won Kim, Chan-Yeong Heo, Jae-Young Lim. 1. Department of Rehabilitation Medicine, Seoul National University College of Medicine, Seoul National University Bundang Hospital, 300 Gumi-dong Bundang-gu, Seongnam-si, Gyeonggi-do, 463-707, Republic of Korea.
Abstract
PURPOSE: The aims of the study were to investigate longitudinal changes in multiple domains of problems with sexual functioning in Korean breast cancer survivors in the first year after surgery for breast cancer and to determine which factor(s), including upper limb dysfunction, may influence sexual problems. METHODS: Women diagnosed with breast cancer (n = 191) were initially assessed at baseline before surgery and completed follow-ups at 3, 6, and 12 months after surgery. Survey items included sexual interest, sexual activity, satisfaction with sex life, feeling sexually attractive, body image, medical history, symptoms, upper limb dysfunction, and sociodemographics. RESULTS: The prevalence of sexually active women was 39.2% at 3 months, which increased to 48.2% at 6 months, and 50% at 12 months after surgery. Compared with pretreatment levels, considerably more women reported moderate or severe problems with sexual interest and sexual activity at 3, 6, and 12 months after surgery. Chemotherapy was related to sexual problems only early after treatment, and surgical procedure (extensive vs. conservative) had no significant effect on sexual problems. Low perceived sexual attractiveness in 3 months after surgery was related to greater overall sexual problems. Lymphedema was significantly related to sexual disinterest at all stages of follow-up and to sexual satisfaction at the 6 month follow-up after adjusting for other predicting factors. CONCLUSIONS: Although sexual activity gradually improved during the first year, more women reported moderate or severe problems with sexual interest and activity over time. Upper limb dysfunction, such as that caused by lymphedema, is a significant factor that may interfere with sexual functioning in breast cancer survivors.
PURPOSE: The aims of the study were to investigate longitudinal changes in multiple domains of problems with sexual functioning in Korean breast cancer survivors in the first year after surgery for breast cancer and to determine which factor(s), including upper limb dysfunction, may influence sexual problems. METHODS:Women diagnosed with breast cancer (n = 191) were initially assessed at baseline before surgery and completed follow-ups at 3, 6, and 12 months after surgery. Survey items included sexual interest, sexual activity, satisfaction with sex life, feeling sexually attractive, body image, medical history, symptoms, upper limb dysfunction, and sociodemographics. RESULTS: The prevalence of sexually active women was 39.2% at 3 months, which increased to 48.2% at 6 months, and 50% at 12 months after surgery. Compared with pretreatment levels, considerably more women reported moderate or severe problems with sexual interest and sexual activity at 3, 6, and 12 months after surgery. Chemotherapy was related to sexual problems only early after treatment, and surgical procedure (extensive vs. conservative) had no significant effect on sexual problems. Low perceived sexual attractiveness in 3 months after surgery was related to greater overall sexual problems. Lymphedema was significantly related to sexual disinterest at all stages of follow-up and to sexual satisfaction at the 6 month follow-up after adjusting for other predicting factors. CONCLUSIONS: Although sexual activity gradually improved during the first year, more women reported moderate or severe problems with sexual interest and activity over time. Upper limb dysfunction, such as that caused by lymphedema, is a significant factor that may interfere with sexual functioning in breast cancer survivors.
Authors: Justine J Speer; Bruce Hillenberg; Dennis P Sugrue; Charla Blacker; Cynthia L Kresge; Veronica B Decker; Dana Zakalik; David A Decker Journal: Breast J Date: 2005 Nov-Dec Impact factor: 2.431
Authors: M A Sprangers; M Groenvold; J I Arraras; J Franklin; A te Velde; M Muller; L Franzini; A Williams; H C de Haes; P Hopwood; A Cull; N K Aaronson Journal: J Clin Oncol Date: 1996-10 Impact factor: 44.544
Authors: Young Ho Yun; Xin Shelley Wang; Jung Suk Lee; Ju Won Roh; Chang Geol Lee; Won Sup Lee; Keun Seok Lee; Soo-Mee Bang; Tito R Mendoza; Charles S Cleeland Journal: J Pain Symptom Manage Date: 2005-02 Impact factor: 3.612
Authors: Leticia Aptecar; Frederic Fiteni; Marta Jarlier; Stephanie Delaine; Violaine Guillerme; William Jacot; Veronique D'Hondt Journal: Breast Cancer Res Treat Date: 2021-01-15 Impact factor: 4.872
Authors: Diana D Jeffery; Lisa Barbera; Barbara L Andersen; Amy K Siston; Anuja Jhingran; Shirley R Baron; Jennifer Barsky Reese; Deborah J Coady; Jeanne Carter; Kathryn E Flynn Journal: J Psychosoc Oncol Date: 2015
Authors: Caleb J Winch; Kerry A Sherman; Louise A Koelmeyer; Katriona M Smith; Helen Mackie; John Boyages Journal: Support Care Cancer Date: 2015-03-27 Impact factor: 3.603
Authors: Christal L Badour; Keith S Cox; Jessica R M Goodnight; Jessica Flores; Peter W Tuerk; Sheila A M Rauch Journal: Psychiatry Date: 2019-10-02 Impact factor: 2.458
Authors: Kayo Togawa; Huiyan Ma; Ashley Wilder Smith; Marian L Neuhouser; Stephanie M George; Kathy B Baumgartner; Anne McTiernan; Richard Baumgartner; Rachel M Ballard; Leslie Bernstein Journal: Sci Rep Date: 2021-05-21 Impact factor: 4.379
Authors: Angelique Bobrie; Marta Jarlier; Aurore Moussion; William Jacot; Veronique D'Hondt Journal: Support Care Cancer Date: 2022-01-14 Impact factor: 3.359